genocea biosciences inc
(GNCA:Consolidated Issue listed on NASDAQ Global Market)
David Bernstein M.D., M.A.
Member of Scientific Advisory Board,Genocea Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 30 board members in 2 different organizations across 2 different industries.|
See Board Relationships
David Bernstein MD, MA serves as Albert Sabin Professor of Pediatrics, Director of Infectious Diseases and Director of the Gamble Program at the Cincinnati Children's Hospital and Medical Center and also directs its one of eight National Institutes of Health-funded Vaccine Evaluation Units. Dr. Bernstein has expertise in vaccines and antivirals against herpes simplex virus and cytomegalovirus, and was instrumental in the development of the precursor to the rotavirus ...
100 Acorn Park DrivePhone: 617-876-8191
Cambridge, Massachusetts 02140
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Kalevi Reijonen M.D.||Chief Executive Officer and President|
FIT Biotech Oy
|Hans Arwidsson Ph.D.||Chief Executive Officer and President|
Eurocine Vaccines AB
|Daniel J. O'Connor Esq.||Chief Executive Officer, President and Director|
|$398.8K||Compensation as of Fiscal Year 2014.|